Safety evaluation of subcutaneous and intravenous administration of infliximab: a real-world study based on the FAERS database
BackgroundInflammatory Bowel Disease (IBD) is characterized by recurrent flare-ups, significantly impairing patients’ long-term quality of life and increasing the risk of complications. As the first chimeric monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α), infliximab blocks TNF-α-m...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2026-06-01
|
| 叢編: | Frontiers in Medicine |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1834815/full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|